Mounjaro weight loss jab: All you need to know
GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service begins its mass rollout.
Some 220,000 people with the 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Lilly, through the NHS over the next three years.
Here the PA news agency takes a look at the drug and the rollout.
– How does tirzepatide work?
Tirzepatide, or Mounjaro, is an antidiabetic drug which lowers blood sugar levels and slows down how quickly food is digested.
It makes you feel fuller for longer and therefore less hungry.
If the jab is recommended by a healthcare professional, those using it will need to eat a balanced, reduced-calorie diet and to exercise regularly while taking it, according to the NHS website.
– Who might be eligible for the drug?
In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of more than 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea.
It was previously only accessible to patients through a special weight loss service, to severely obese people who also suffer from a range of other health problems.
Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription.
– How would it be administered?
The drug is usually delivered through a self-administered weekly injection which a doctor or nurse will show patients how to use, the NHS website says.
– Who cannot take tirzepatide?
Mounjaro is not recommended for those who are pregnant or planning to get pregnant, breastfeeding or have certain health conditions, according to the NHS.
For those taking the contraceptive pill and using tirzepatide, the NHS recommends using an additional method of contraception, such as a condom, for the first four weeks of treatment and for four weeks after each dose increase as the contraceptive pill may not be absorbed by the body during this time.
– What are the potential side effects?
Potential side effects of tirzepatide include nausea, vomiting, diarrhoea and constipation, according to the National Institute for Health and Care Excellence.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Government launches national investigation into NHS maternity services
A national investigation into NHS maternity services has been launched by Health Secretary Wes Streeting. The new rapid investigation is intended to provide truth to families suffering harm, as well as driving urgent improvements to care and safety. It comes after Mr Streeting met families who have lost babies and amid the ongoing investigations at some NHS trusts into poor maternity care.
Washington Post
an hour ago
- Washington Post
In West Virginia, Medicaid is a lifeline. GOP cuts could devastate the state.
ROMNEY, — Hampshire Memorial Hospital is nestled deep in the Appalachian Mountains, past more than 20 miles of winding mountain roads dotted with lush trees and ridges. It is the only hospital for a county that spans 645 square miles and, for many of its 24,000 residents, is the sole option for health care ranging from routine ailments to life-threatening emergencies.
Washington Post
an hour ago
- Washington Post
Insurers vow to make prior authorization for treatment easier. What that means.
Major health insurers are promising to ease up on a cost-controlling practice long hated by doctors and patients for making it harder to get quick and efficient care. Several dozen insurers — including insurance giants UnitedHealthcare, Elevance, Aetna, Cigna and Kaiser Permanente — announced Monday that they will make this practice, known as 'prior authorization,' more efficient and transparent over the next 18 months.
